Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
Bias01:22

Bias

Bias refers to any tendency that prevents a question from being considered unprejudiced. In research, bias occurs when one outcome or answer is selected or encouraged over others in sampling or testing. Bias can occur during any research phase, including study design, data collection, analysis, and publication.
In statistics, a sampling bias is created when a sample is collected from a population, and some members of the population are not as likely to be chosen as others (remember, each member...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tracking positive emotions in the course of adult depression: A systematic scoping review of longitudinal studies.

Journal of affective disorders·2025
Same author

Response to: ROBINS-E risk of bias tool.

Environment international·2025
Same author

Trial analysis by treatment allocated or by treatment received? Origins of 'the intention-to-treat principle' to reduce allocation bias: Part 2.

Journal of the Royal Society of Medicine·2023
Same author

Trial analysis by treatment allocated or by treatment received? Origins of 'the intention-to-treat principle' to reduce allocation bias: Part 1.

Journal of the Royal Society of Medicine·2023
Same author

Biomedical doctoral students' research practices when facing dilemmas: two vignette-based randomized control trials.

Scientific reports·2023
Same author

2-Year outcome from two parallel randomized controlled trials. Reporting considerations.

Osteoarthritis and cartilage·2018

Related Experiment Video

Updated: May 28, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Blinding in randomized clinical trials: imposed impartiality.

A Hróbjartsson1, I Boutron

  • 1The Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark. ah@cochrane.dk

Clinical Pharmacology and Therapeutics
|October 14, 2011
PubMed
Summary
This summary is machine-generated.

Blinding, crucial for reducing bias in randomized clinical trials, involves masking patients, providers, and assessors to treatment allocation. Rigorous testing and transparent reporting of blinding methods are essential for trial integrity.

More Related Videos

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

Related Experiment Videos

Last Updated: May 28, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

Area of Science:

  • Clinical Trials Methodology
  • Evidence-Based Medicine
  • Research Integrity

Background:

  • Bias in randomized clinical trials (RCTs) can compromise results.
  • Blinding (masking) is a key strategy to mitigate performance and detection bias.
  • Understanding blinding's nuances is vital for reliable trial outcomes.

Purpose of the Study:

  • To review methodological aspects of blinding in RCTs.
  • To emphasize terminology, reporting standards, bias, and unblinding risks.
  • To advocate for robust blinding procedures and transparent reporting.

Main Methods:

  • Literature review of blinding in clinical trials.
  • Analysis of theoretical considerations and empirical evidence.
  • Examination of bias mechanisms and unblinding risks.

Main Results:

  • Blinding of patients, healthcare providers, and outcome assessors is supported by evidence.
  • Potential bias mechanisms and risks associated with unblinding are identified.
  • The importance of pretrial testing and explicit reporting is highlighted.

Conclusions:

  • Effective blinding is fundamental to reducing bias in RCTs.
  • Standardized reporting and rigorous testing of blinding methods are recommended.
  • Ensuring blinding integrity enhances the validity of clinical trial findings.